Confidentiality of Patient Records
This document discusses the AMA's policy on supporting the basic right of patients to privacy of their medical information and their right to control access to their information.... Details >
American Medical Association |
Federal Trade Commission Health Care Antitrust Issues
This page links users to information on issues from the health care antitrust arena including statements of antitrust enforcement policy in health care, Federal Trade Commission antitrust actions in h... Details >
Federal Trade Commission |
How to Report Problems With Products Regulated by FDA
Consumers are urged to report defective and problematic products to the FDA. The evaluation procedures for foods, drugs, cosmetics, medical devices, and veterinary drugs are described. ... Details >
U.S. Food and Drug Administration |
Medical Errors & Patient Safety
Following a report by the Institute of Medicine (IOM) estimating that up to 98,000 Americans die each year as a result of preventable medical errors, President Clinton directed the Quality Interagency... Details >
Agency for Healthcare Research and Quality |
Patient's Bill of Rights -- American Academy of Pain Management
The American Academy of Pain Management's compliance with the Patient's Bill of Rights. The American Hospital Association's statement on a patient's Bill of Rights has been incorporated as part of t... Details >
American Academy of Pain Management |
Questions and Answers for Withdrawal of Duract
Answers to consumers' questions concerning the withdrawal of Duract from the market and FDA's recommendation that patients stop taking the drug after reports of a rare but serious liver problem as mor... Details >
Center for Drug Evaluation and Research, U.S. Food and Drug Administration |
Report to the President on Medical Errors
The President ordered the Quality Interagency Coordination Task Force to make recommendations for improving health care quality and protecting patient safety following a report from the Institute of M... Details >
Agency for Healthcare Research and Quality |
Warning Letters and Notice of Violation Letters to Pharmaceutical Companies
These letters, sorted by month, are supplied by the CDER Freedom of Electronic Information Office. Some of the letters have been redacted or edited to remove confidential information.... Details >
Center for Drug Evaluation and Research, U.S. Food and Drug Administration |
